{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:36:00Z","timestamp":1787664960797,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022554","name":"Institut du Cerveau et de la Moelle Epini\u00e8re","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jacbts.2024.12.015","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T15:07:00Z","timestamp":1741792020000},"page":"759-782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Long-Term Dystrophin Replacement Therapy in Duchenne Muscular Dystrophy Causes Cardiac Inflammation"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4970-2372","authenticated-orcid":false,"given":"Anne","family":"Forand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Moog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Mougenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9gane","family":"Lemaitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Sevoz-Couche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoheir","family":"Guesmia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Virtanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Giordani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Muchir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"France","family":"Pietri-Rouxel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2024.12.015_bib1","series-title":"StatPearls","article-title":"Dystrophinopathies","author":"Morales","year":"2023"},{"key":"10.1016\/j.jacbts.2024.12.015_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/jamaneurol.2015.3537","article-title":"Identifying non\u2013Duchenne muscular dystrophy\u2013positive and false negative results in prior duchenne muscular dystrophy newborn screening programs: a review","volume":"73","author":"Gatheridge","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jacbts.2024.12.015_bib3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jacbts.2024.12.015_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/338259a0","article-title":"Association of dystrophin and an integral membrane glycoprotein","volume":"338","author":"Campbell","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.jacbts.2024.12.015_bib5","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","article-title":"Dystrophin-deficient cardiomyopathy","volume":"67","author":"Kamdar","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2024.12.015_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/13543784.2021.1868434","article-title":"Developing DMD therapeutics: a review of the effectiveness of small molecules, stop-codon readthrough, dystrophin gene replacement, and exon-skipping therapies","volume":"30","author":"Sheikh","year":"2021","journal-title":"Exp Opin Invest Drugs"},{"key":"10.1016\/j.jacbts.2024.12.015_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.omtm.2023.05.017","article-title":"Evaluation of an AAV9-mini-dystrophin gene therapy candidate in a rat model of Duchenne muscular dystrophy","volume":"30","author":"Le Guiner","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jacbts.2024.12.015_bib8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nm1439","article-title":"rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice","volume":"12","author":"Gregorevic","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jacbts.2024.12.015_bib9","first-page":"1","article-title":"2022 ASGCT annual meeting late-breaking abstracts. A collaborative analysis by clinical trial sponsors and academic experts of anti-transgene SAEs in studies of gene therapy for DMD","volume":"30","author":"Bonnemann","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.jacbts.2024.12.015_bib10","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.jacbts.2024.12.015_bib11","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1093\/hmg\/ddz128","article-title":"AAV-based gene therapies for the muscular dystrophies","volume":"28","author":"Crudele","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacbts.2024.12.015_bib12","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.3233\/JND-210678","article-title":"Gene therapy for Duchenne muscular dystrophy","volume":"8","author":"Elangkovan","year":"2021","journal-title":"JND"},{"key":"10.1016\/j.jacbts.2024.12.015_bib13","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMc2212912","article-title":"Dystrophin immunity after gene therapy for Duchenne\u2019s muscular dystrophy","volume":"388","author":"B\u00f6nnemann","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacbts.2024.12.015_bib14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.omtm.2020.03.011","article-title":"Combined treatment with peptide-conjugated phosphorodiamidate morpholino oligomer-PPMO and AAV-U7 rescues the severe DMD phenotype in mice","volume":"17","author":"Forand","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jacbts.2024.12.015_bib15","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1089\/hum.2011.020","article-title":"Delivery of AAV2\/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of \u03b11-syntrophin and \u03b1-dystrobrevin in skeletal muscles of mdx mice","volume":"22","author":"Koo","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jacbts.2024.12.015_bib16","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/mt.2008.186","article-title":"Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2\/8 gene transfer","volume":"16","author":"Foster","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.jacbts.2024.12.015_bib17","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1093\/hmg\/dds082","article-title":"Rescue of severely affected dystrophin\/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping","volume":"21","author":"Goyenvalle","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacbts.2024.12.015_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2024.12.015_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13395-016-0096-4","article-title":"Dystrophin restoration therapy improves both the reduced excitability and the force drop induced by lengthening contractions in dystrophic mdx skeletal muscle","volume":"6","author":"Roy","year":"2016","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.jacbts.2024.12.015_bib20","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cels.2018.02.010","article-title":"Compensation of signal spillover in suspension and imaging mass cytometry","volume":"6","author":"Chevrier","year":"2018","journal-title":"Cell Syst"},{"key":"10.1016\/j.jacbts.2024.12.015_bib21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.jacbts.2024.12.015_bib22","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/s41467-023-37123-6","article-title":"IMC-Denoise: a content aware denoising pipeline to enhance imaging mass cytometry","volume":"14","author":"Lu","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2024.12.015_bib23","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1038\/s41596-023-00881-0","article-title":"An end-to-end workflow for multiplexed image processing and analysis","volume":"18","author":"Windhager","year":"2023","journal-title":"Nat Protocol"},{"key":"10.1016\/j.jacbts.2024.12.015_bib24","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"10.1016\/j.jacbts.2024.12.015_bib25","series-title":"R: a language and environment for statistical computing","year":"2024"},{"key":"10.1016\/j.jacbts.2024.12.015_bib26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","article-title":"Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy","volume":"90","author":"Deconinck","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.jacbts.2024.12.015_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13395-017-0124-z","article-title":"The golden retriever model of Duchenne muscular dystrophy","volume":"7","author":"Kornegay","year":"2017","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.jacbts.2024.12.015_bib28","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.21627","article-title":"Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs","volume":"65","author":"Yokota","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jacbts.2024.12.015_bib29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41582-019-0203-3","article-title":"Therapeutic developments for Duchenne muscular dystrophy","volume":"15","author":"Verhaart","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jacbts.2024.12.015_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10554-010-9781-2","article-title":"Patterns of left ventricular remodeling in patients with Duchenne muscular dystrophy: a cardiac MRI study of ventricular geometry, global function, and strain","volume":"28","author":"Mazur","year":"2012","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jacbts.2024.12.015_bib31","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0002-9149(79)90152-8","article-title":"Left ventricular radius to wall thickness ratio","volume":"43","author":"Gaasch","year":"1979","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacbts.2024.12.015_bib32","doi-asserted-by":"crossref","first-page":"7152","DOI":"10.3390\/jcm11237152","article-title":"Interventricular septum thickness for the prediction of coronary heart disease and myocardial infarction in hypertension population: a prospective study","volume":"11","author":"Yang","year":"2022","journal-title":"JCM"},{"key":"10.1016\/j.jacbts.2024.12.015_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.nmd.2018.01.012","article-title":"Normalization of connexin 43 protein levels prevents cellular and functional signs of dystrophic cardiomyopathy in mice","volume":"28","author":"Gonzalez","year":"2018","journal-title":"Neuromusc Disord"},{"key":"10.1016\/j.jacbts.2024.12.015_bib34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-2478(03)00002-6","article-title":"IL-10, an inflammatory\/inhibitory cytokine, but not always","volume":"86","author":"Conti","year":"2003","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jacbts.2024.12.015_bib35","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jacbts.2024.12.015_bib36","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1182\/blood-2008-07-167510","article-title":"AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells","volume":"114","author":"Mingozzi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jacbts.2024.12.015_bib37","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev-virology-101416-041936","article-title":"Overcoming the host immune response to adeno-associated virus gene delivery vectors: the race between clearance, tolerance, neutralization, and escape","volume":"4","author":"Mingozzi","year":"2017","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.jacbts.2024.12.015_bib38","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1089\/hum.2016.172","article-title":"Impact of AAV capsid-specific T-cell responses on design and outcome of clinical gene transfer trials with recombinant adeno-associated viral vectors: an evolving controversy","volume":"28","author":"Ertl","year":"2017","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jacbts.2024.12.015_bib39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.12688\/f1000research.12491.1","article-title":"Emerging therapies for hemophilia: controversies and unanswered questions","volume":"7","author":"Arruda","year":"2018","journal-title":"F1000 Res"},{"key":"10.1016\/j.jacbts.2024.12.015_bib40","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1517\/21678707.2015.1069179","article-title":"Obstacles and future of gene therapy for hemophilia","volume":"3","author":"Arruda","year":"2015","journal-title":"Exp Opin Orphan Drugs"},{"key":"10.1016\/j.jacbts.2024.12.015_bib41","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165869","article-title":"Potential limitations of micro-dystrophin gene therapy for Duchenne muscular dystrophy","volume":"9","author":"Hart","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacbts.2024.12.015_bib42","doi-asserted-by":"crossref","DOI":"10.1098\/rsfs.2014.0080","article-title":"Multiscale models of skeletal muscle reveal the complex effects of muscular dystrophy on tissue mechanics and damage susceptibility","volume":"5","author":"Virgilio","year":"2015","journal-title":"Interface Focus"},{"key":"10.1016\/j.jacbts.2024.12.015_bib43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1096\/fj.12-208967","article-title":"Resisting sarcolemmal rupture: dystrophin repeats increase membrane-actin stiffness","volume":"27","author":"Sarkis","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.jacbts.2024.12.015_bib44","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/gt.2014.53","article-title":"Exon skipping restores dystrophin expression, but fails to prevent disease progression in later stage dystrophic dko mice","volume":"21","author":"Wu","year":"2014","journal-title":"Gene Ther"},{"key":"10.1016\/j.jacbts.2024.12.015_bib45","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146511","article-title":"Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model","volume":"6","author":"Howard","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacbts.2024.12.015_bib46","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/mt.2011.154","article-title":"AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice","volume":"19","author":"Bostick","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.jacbts.2024.12.015_bib47","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yjmcc.2012.05.002","article-title":"AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in > 21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy","volume":"53","author":"Bostick","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2024.12.015_bib48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/ng0598-79","article-title":"Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice","volume":"19","author":"Rafael","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacbts.2024.12.015_bib49","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012443","article-title":"Natural history of cardiomyopathy in adult dogs with golden retriever muscular dystrophy","volume":"8","author":"Guo","year":"2019","journal-title":"JAHA"},{"key":"10.1016\/j.jacbts.2024.12.015_bib50","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.omtm.2023.02.001","article-title":"Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model","volume":"28","author":"Piepho","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jacbts.2024.12.015_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo1815","article-title":"Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy","volume":"15","author":"Birch","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jacbts.2024.12.015_bib52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nmd.2022.12.007","article-title":"Clinical potential of microdystrophin as a surrogate endpoint","volume":"33","author":"Boehler","year":"2023","journal-title":"Neuromusc Disord"},{"key":"10.1016\/j.jacbts.2024.12.015_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.45","article-title":"100-Fold but not 50-fold dystrophin overexpression aggravates electrocardiographic defects in the mdx model of Duchenne muscular dystrophy","volume":"3","author":"Yue","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jacbts.2024.12.015_bib54","doi-asserted-by":"crossref","first-page":"10109","DOI":"10.1073\/pnas.91.21.10109","article-title":"Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy","volume":"91","author":"Milano","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jacbts.2024.12.015_bib55","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1172\/JCI119727","article-title":"Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice","volume":"100","author":"Colbert","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacbts.2024.12.015_bib56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1008894507995","article-title":"Transgenic over-expression of a motor protein at high levels results in severe cardiac pathology","volume":"8","author":"James","year":"1999","journal-title":"Transgenic Res"},{"key":"10.1016\/j.jacbts.2024.12.015_bib57","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/74914","article-title":"Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy","volume":"6","author":"Huang","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.jacbts.2024.12.015_bib58","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1026055612227","article-title":"Cardiac expression of Gal4 causes cardiomyopathy in a dose-dependent manner","volume":"24","author":"Habets","year":"2003","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1016\/j.jacbts.2024.12.015_bib59","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.3233\/JND-210706","article-title":"The effect of immunomodulatory treatments on anti-dystrophin immune response after AAV gene therapy in dystrophin deficient mdx mice","volume":"8","author":"Li","year":"2021","journal-title":"JND"},{"key":"10.1016\/j.jacbts.2024.12.015_bib60","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/bph.14155","article-title":"Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges","volume":"175","author":"Huang","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacbts.2024.12.015_bib61","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1161\/CIRCRESAHA.121.318005","article-title":"Immune cells and immunotherapy for cardiac injury and repair","volume":"128","author":"Rurik","year":"2021","journal-title":"Circ Res"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X2400490X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X2400490X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T18:33:47Z","timestamp":1762626827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X2400490X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2452302X2400490X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2024.12.015","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Dystrophin Replacement Therapy in Duchenne Muscular Dystrophy Causes Cardiac Inflammation","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2024.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}